# Voyager Therapeutics, Inc.: Form 8-K, filed Nov 8, 2022

- Company: [Voyager Therapeutics, Inc.](/companies/vygr.md) (CIK 1640266)
- Form: 8-K
- Filed: 2022-11-08
- Accepted by EDGAR: Nov 8, 2022, 07:03 ET
- Period: 2022-11-08
- Accession: 0001558370-22-016731
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1640266/000155837022016731/vygr-20221108x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1640266/000155837022016731/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1640266/000155837022016731/vygr-20221108x8k.htm

Filed Nov 8, 2022.
Source: SEC EDGAR, the filing index for accession 0001558370-22-016731. Last ingested by Listed: Nov 5, 2026, 16:29 ET. No prices; not investment advice.
